Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth

Author's Avatar
Dec 12, 2022

Designed to support revenue growth by expanding biotres form factors for the early detection of cardiac arrhythmias in the $5 billion-dollar holter monitor market